Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

UNC Lineberger Comprehensive Cancer Center

Status: Completed

Conditions: Oncology

Treatments: Other: Results of the brief geriatric assessment; Other: No results of brief geriatric assessments

Study type: Interventional

Funder types: Other

Identifiers

NCT03951090

LCCC 1538

Details and patient eligibility

About

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (> 70 years) adults with cancer.

Full description

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.

This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Enrollment: 148 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 70 years or older.
• English speaking.
• Admitted to UNC Hospitals non-electively within 72 hours.
• Biopsy proven solid tumor or myeloma or lymphoma.
• Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
• Signed written IRB-approved informed consent.

Exclusion criteria

• Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
• Patients who are <48 hours post-surgery.
• Patients who are admitted to an intensive care setting.
• Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
• Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

148 participants in 2 patient groups

GARRT Arm

Experimental group

Description:

Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment

Treatment:

Other: Results of the brief geriatric assessment

Control Arm

Active Comparator group

Description:

Providers of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment

Treatment:

Other: No results of brief geriatric assessments